openPR Logo
Press release

Telmisartan Market Business Opportunity 2020: Solco Healthcare, Macleods Pharmaceuticals, Jubilant Cadista, Torrent Pharmaceuticals, Exelan Pharmaceuticals

03-10-2021 11:48 AM CET | Health & Medicine

Press release from: The Insight Partners

Telmisartan Market Forecast to 2027

Telmisartan Market Forecast to 2027

The insight Partners Research has recently added a concise research on the Global Telmisartan Market – Industry Trends and Forecast to 2027. A reliable Global Telmisartan Market report contains market data that can be relatively essential when it comes to dominate in the industry or make a mark in the market as a new emergent. It also strategically analyses the growth trends and future prospects. Moreover, this winning market report also provides strategic profiling of top players in the industry, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. The report gives details about the top players and brands that are driving the market. A wide-ranging research report acts as a backbone for the success of business in any sector.

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.

Request for sample Copy at: https://www.theinsightpartners.com/sample/TIPRE00005565/?openpr-10144

Key Market Competitors: Global Telmisartan Market

Mylan N.V.
Hikma Pharmaceuticals PLC
Exelan Pharmaceuticals, Inc.
Macleods Pharmaceuticals Ltd.
Zydus Pharmaceuticals, Inc.
Torrent Pharmaceuticals Ltd.
Jubilant Cadista.
Aurobindo Pharma.
Solco Healthcare
Sandoz International GmbH

The global Telmisartan markets is segmented on the basis of indication, composition and distribution channel. Based on indication, the market is segmented as hypertension, cardiac arrest and stroke. Based on composition the Telmisartan market is segmented into single and combinational. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

The global Telmisartan market is expected to grow in upcoming years. Factors driving the growth of market are increasing prevalence of high blood pressure, increase in incidences of chronic diseases such as diabetes, growth in geriatric population and others. On the other hand rise on approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets is expected to offer growth opportunities in telmisartan market.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Telmisartan market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Telmisartan market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Telmisartan Market - By Indication
1.3.2 Telmisartan Market - By Composition
1.3.3 Telmisartan Market - By Distribution Channel
1.3.4 Telmisartan Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TELMISARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. TELMISARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS

Purchase Full Copy of this report at: https://www.theinsightpartners.com/buy/TIPRE00005565/?openpr-10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Telmisartan Market Business Opportunity 2020: Solco Healthcare, Macleods Pharmaceuticals, Jubilant Cadista, Torrent Pharmaceuticals, Exelan Pharmaceuticals here

News-ID: 2254415 • Views:

More Releases from The Insight Partners

Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that
Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129 Consumer Genomics Market: Competitive Landscape and Key Developments: •

All 5 Releases


More Releases for Telmisartan

Telmisartan Market to witness Excessive Growth, Observe the latest Development a …
The global Telmisartan market was valued at 3154.67 Million USD in 2020 and will grow with a CAGR of .77% from 2020 to 2027, based on a newly published report. The latest research on Telmisartan Market provides a thorough examination of the most current developments in the Telmisartan and the key dynamics that are driving growth. It is a research report that examines market drivers, restraints, challenges, risks, and development prospects
Telmisartan Market Drives, Emerging Trends, Key Value And Forecast 2031
Telmisartan, medication sold under the brand name Micardis is consumed alone or in combination with other medications for decreasing the chances of heart attack or stroke among people above 55 years of age. The medication is consumed to control high blood pressure but cannot treat it. Telmisartan is an angiotensin II receptor blocker. As the medication lowers the blood pressure and blood and oxygen flow towards the heart more easily, therefore relaxes
Telmisartan Dispersible Tablets Market - Global Industry Analysis, Size, Share, …
The Global Telmisartan Dispersible Tablets Market report offers a comprehensive evaluation of the market. It does give in-depth analysis via qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. The report contains detailed analysis of Telmisartan Dispersible Tablets market growth, segmentation, regional and country breakdowns. It can provide a detailed study of the drivers,
Telmisartan Market Prophesied to Grow at a Faster Pace by 2026
Availability of better treatment options for hypertension has lead substantial portion of the hypertensive population with controlled blood pressure. But rising population with cardiovascular, and associated disorders urges need for different antihypertensive drugs in the global market. Telmisartan is a non-peptide angiotensin receptor blocker intended for treatment of hypertension and other cardiovascular disorders. Telmisartan was approved by the US Food and Drug Administration (USFDA) in 1998, for the treatment of
Telmisartan Sales Market 2017: Rising Demand For Coming Years
Qyresearchreports include new market research report “Global Telmisartan Sales Market Report 2017” to its huge collection of research reports. This report on the global Telmisartan market has been developed by a selected group of professional market research analysts, with a solitary goal to present the current scenario of the market for Telmisartan and throw light on its growth prospects. The report targets audiences such as manufacturers of Telmisartan, government agencies, and
Global Telmisartan Market – Industry Analysis and Future Forecast by 2021 with …
Qyresearchreports include new market research report “Global Telmisartan Market 2016 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast to 2021″ to its huge collection of research reports. The global Telmisartan is the core objective of examination in this research report recently added to our extensive database. The report to a great degree is a spellbinding and savvy archive that helps chalk out a careful and comprehensive investigative Telmisartan, covering